Evaluation of the effect of vitamin E therapy on children with acute kidney injury

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231119060103N1

Enrollment

Registered

2023-11-24

Start date

2023-11-12

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury. Acute kidney failure, unspecified

Interventions

Intervention 1: intervention group In addition to the routine treatment with fluid therapy, patients are given vitamin E drops from the "Behsa" company, each milliliter of which contains 10 internatio

Eligibility

Sex/Gender

All

Age

1 Years to 13 Years

Inclusion criteria

Inclusion criteria: 1. People with acute kidney injury between the ages of 1 and 13 admitted to Amirkabir Hospital 2. Have the necessary cooperation in following up the treatment 3. Completing the informed consent form.

Exclusion criteria

Exclusion criteria: People who do not want to participate in the study

Design outcomes

Primary

Measure	Time frame
The assessment of acute kidney injury is done by measuring the serum creatinine level. Timepoint: Measurement of serum creatinine level at the beginning of the study, 48 hours later and at the time of discharge. Method of measurement: blood sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ali Arjmand

Arak University of Medical Sciences

Aliarjmand1@yahoo.com+98 86 3313 4715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026